Advertisement Quanticate names new president of US operations - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quanticate names new president of US operations

Quanticate, a global biometrics clinical research organization, has appointed Andrew MacGarvey as president of its US operations headquartered in Cambridge, Massachusetts.

The appointment signals the company’s mission to further expand its clinical trial service capabilities with Mr MacGarvey managing the company’s initiatives in support of existing and new US clients.

In addition, Mr MacGarvey will continue to direct the company’s global sales efforts. Prior to joining Quanticate, Mr MacGarvey served as a director at Datatrial, a provider of clinical data management solutions.

Mr MacGarvey said: “The move to establishing a US headquarters is in response to the terrific reception of our products by companies here in the states. We have been handling clinical trials for our US customers here and overseas for some time. Our mission now is to grow the office and add more operational elements in line with our customers’ requirements.”